Acetoacetic acid sodium salt in metabolic assays
2026-09-23
Acetoacetic acid sodium salt provides a water-soluble, non-esterified ketone body input for controlled studies of fatty acid catabolism and diabetes-related metabolic imbalance. This guide combines practical dosing, matrix controls, storage discipline, and analytical lessons from isotope-labeled synthesis research.
Pregnancy, LNP Design, and mRNA Delivery
2026-09-22
The reference study shows that lipid nanoparticle structure and administration route jointly determine mRNA expression, inflammatory responses, placental immune changes, and postnatal growth in pregnant mice. Its main contribution is a mechanism-based framework for evaluating potency and maternal–fetal safety together rather than treating delivery efficiency as an isolated endpoint.
ALC-0159 for mRNA LNP Workflow Design
2026-09-22
ALC-0159 is a PEG-conjugated lipid excipient for building and refining mRNA lipid nanoparticles, not a standalone immunotherapy. This workflow connects formulation control with cancer-immunotherapy research while separating what the reference study demonstrated from what must be validated experimentally.
Anti Reverse Cap Analog for mRNA Translation
2026-09-21
Use Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G to build directionally capped synthetic mRNA for stronger translation, stability, and reproducible nanoparticle workflows. This practical guide connects in vitro transcription optimization with mRNA therapeutics research, including assay design inspired by targeted delivery after ischemic stroke.
Cy7 NHS Ester: Aqueous Labeling and QC Guide
2026-09-21
Cy7 NHS ester (SKU A8109) is a water-soluble near-infrared dye for bioimaging and amino-group labeling of proteins and peptides, particularly when organic co-solvents could compromise sample stability. It is suitable for freshly prepared labeling workflows and near-infrared fluorescent imaging, but it should not be treated as a long-term solution reagent or as a validated site-specific labeling method.
TCAIM Controls Mitochondrial Metabolism via OGDH
2026-09-20
A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The work expands the role of mitochondrial proteostasis from protein folding toward regulated control of metabolic enzyme abundance and carbohydrate catabolism.
3-Dehydroteasterone Derivatives: Assay-Dependent Activity
2026-09-19
A 2025 study synthesized 3-dehydroteasterone analogs bearing a 23,24-dinorcholanic side chain and substituted benzoate groups, then evaluated them in rice and bean growth bioassays. Its central finding is that benzoate substitution, C-3 oxidation state, and side-chain hydroxylation produce strongly assay-dependent activity, with one ortho-acetoxy derivative approaching brassinolide activity in the rice lamina inclination test.
Indomethacin Workflows for Inflammation Research
2026-09-19
Build more informative inflammation, adipocyte, and membrane assays with Indomethacin, a COX-focused perturbation tool that also supports exploratory PPAR and lipid studies. This practical guide connects dose selection, solvent control, beige-adipocyte readouts, and troubleshooting without treating one biochemical value as a universal cellular dose.
RITA (NSC 652287): A Smarter Response Map
2026-09-18
RITA (NSC 652287) is a mechanistically distinctive p53-pathway research compound. This guide shows how to pair growth-inhibition, cell-death, DNA-damage, and xenograft readouts so an apoptosis assay produces a more interpretable cancer biology profile.
HyperPFU™ high-fidelity DNA polymerase Guide
2026-09-17
HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or sticky-end generation.
HyperPFU™ High-Fidelity DNA Polymerase Guide
2026-09-17
HyperPFU™ high-fidelity DNA polymerase is designed for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended cloning and sequencing workflows, but not for protocols that require direct 3′-A overhangs or sticky ends.
Cytochalasin D: An Actin-Centered Translational Lens
2026-09-16
Cytochalasin D is more than a cytoskeletal inhibitor: it is a mechanistic probe for testing how actin remodeling governs cell-cycle control, cancer phenotypes, viral processes, and nanoparticle uptake across epithelial barriers.
BRD4–RAC1 Co-targeting in Breast Cancer
2026-09-16
Ali et al. describe a subtype-aware strategy that combines BRD4 inhibition with RAC1 blockade to suppress breast cancer growth, stemness, migration, and xenograft tumorigenesis. The study links these effects to disruption of the c-MYC–G9a–FTH1 axis and downregulation of HDAC1-dependent chromatin regulation, providing a mechanistic rationale for combinatorial epigenetic targeting.
Targeted mRNA Nanoparticles in Ischemic Stroke
2026-09-15
The ACS Nano study developed mannose receptor-targeted lipid nanoparticles carrying IL-10 mRNA to reprogram microglia, reduce neuroinflammation, and restore blood–brain barrier integrity after ischemic stroke. Its two-model design links lesion-selective delivery with improvements in tissue injury and neurological function, while also defining important limitations for translation to mRNA therapeutics research.
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-09-15
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based hybridization workflows. It is intended for research applications such as in situ hybridization and Northern blotting, not for diagnostic, therapeutic, or medical use.